Kailos Genetics Announces Co-marketing Agreement with Illumina, Inc. for Pharmacogenetics Solution for Research

Agreement expands Kailos’ use of market-leading next-generation sequencing solutions March 21, 2017 06:00 AM Pacific Daylight Time HUNTSVILLE, Ala.–(BUSINESS WIRE)–Kailos Genetics, a personalized medicine company offering a leading-edge suite of tools for next-generation sequencing (NGS)-based assays, today announced it has entered into a co-marketing agreement with Illumina, Inc. (NASDAQ: ILMN). Under the terms of the... Read more

Agilent Technologies Enhances Exome Sequencing for Clinical Research

New Target Enrichment Product Delivers Deep Coverage of Disease Relevant Content SANTA CLARA, Calif., March 21, 2017 Agilent Technologies Inc. (NYSE: A) today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the... Read more

Agilent Technologies Hires Samraat “Sam” Raha to Head Strategy and Corporate Development

Former Agilent Commercial VP Brings Deep Industry and Marketing Experience to New Role SANTA CLARA, Calif., March 20, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Samraat “Sam” Raha has been named senior vice president of strategy and corporate development, reporting to Agilent President and CEO Mike McMullen. Raha will serve as strategic lead... Read more

Edico Genome Expands Intellectual Property Portfolio with an Additional Five Patents Issued for DRAGEN Platform

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more

DNAnexus Announces Two Key Executive Appointments

Industry veterans bring extensive expertise and insight as DNAnexus powers increasingly complex precision medicine projects March 15, 2017 01:31 PM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus Inc., the global leader in genome informatics and data management, today announced the promotion of George Asimenos, Ph.D. to Chief Technology Officer (CTO) and the addition of Fan... Read more

Thermo Fisher Scientific Introduces the QuantStudio 5 Real-Time PCR System for the Modern Forensic Laboratory

CARLSBAD, Calif.–(BUSINESS WIRE)–Forensic scientists who want to modernize their laboratories now have access to the Applied Biosystems QuantStudio 5 Real-Time PCR System for Human Identification. Paired with the complementary analysis software and Thermo Fisher Scientific’s leading DNA chemistries, the complete solution is designed to meet evolving needs and help labs stay ahead of future technological... Read more

GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare

Wauwatosa, Wisconsin – 13 March 2017 – Monitoring expectant mothers and their babies before and during childbirth is a vital and at times a complicated task. GE Healthcare is investing in innovations to make it easier. Today, GE Healthcare announced that it is expanding its Maternal-Infant Care business with the acquisition of Monica Healthcare, a... Read more

Zymo Research Launches Discovery Series™ Nucleic Acid Kits for Greater Flexibility and Convenience

Kits are now available in 5- and 10-prep/reaction format NEWS PROVIDED BY Zymo Research Corp. 28 Feb, 2017, 11:05 ET IRVINE, Calif., Feb. 28, 2017 /PRNewswire/ — Zymo Research announces the launch of its Discovery Series™ DNA and RNA purification kits. The new product line includes eight of Zymo Research’s most popular kits in a... Read more

Takara Bio USA Holdings, Inc. completes acquisition of WaferGen Bio-systems, Inc.

Takara Bio USA Holdings, Inc. completes acquisition of WaferGen Bio-systems, Inc. Mountain View, CA—March 1, 2017—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of WaferGen Bio-systems, Inc. (“WaferGen”), WaferGen has become a wholly-owned subsidiary of TBUSH as of February 28, 2017 (US local time). Under the merger agreement executed with... Read more

Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business

CAMBRIDGE, UK – 27 February, 2017 – Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners (Amadeus) participated alongside new investor, Parkwalk Advisors (Parkwalk). Congenica will use the Series B... Read more